Search Results for: Kaiser Permanente

Mavenclad (cladribine) was first submitted to the FDA in October 2009 as a potential oral short-course multiple sclerosis therapy. Merck then received ... Read More

Ocrevus is a drug used for relapsing and primary progressive forms of multiple sclerosis. The FDA granted priority review to Genentech for an Ocrevus ... Read More

Mayzent (Siponimod) is a medication used to treat relapsing forms of multiple sclerosis. Mazyent is considered especially significant as it was the ... Read More

Received a Qulipta Health Insurance Denial? Contact Us Qulipta (atogepant) received FDA approval in September 2021 for the preventive treatment of ... Read More

Received a Nurtec Health Insurance Denial? Contact Us More than a billion people across the globe suffer from migraines. The World Health ... Read More

Received a RINVOQ Health Insurance Denial? Contact Us RINVOQ (Upadacitinib) has received numerous FDA approvals for a variety of conditions ... Read More